The DOI matches its Crossref record; 255 of the 255 references it cites were found in a registry or an index.
Protein kinase CK2: a potential therapeutic target for diverse human diseases
Open accessAbstract
CK2 is a constitutively active Ser/Thr protein kinase, which phosphorylates hundreds of substrates, controls several signaling pathways, and is implicated in a plethora of human diseases. Its best documented role is in cancer, where it regulates practically all malignant hallmarks. Other well-known functions of CK2 are in human infections; in particular, several viruses exploit host cell CK2 for their life cycle. Very recently, also SARS-CoV-2, the virus responsible for the COVID-19 pandemic, has been found to enhance CK2 activity and to induce the phosphorylation of several CK2 substrates (either viral and host proteins). CK2 is also considered an emerging target for neurological diseases, inflammation and autoimmune disorders, diverse ophthalmic pathologies, diabetes, and obesity. In addition, CK2 activity has been associated with cardiovascular diseases, as cardiac ischemia–reperfusion injury, atherosclerosis, and cardiac hypertrophy. The hypothesis of considering CK2 inhibition for cystic fibrosis therapies has been also entertained for many years. Moreover, psychiatric disorders and syndromes due to CK2 mutations have been recently identified. On these bases, CK2 is emerging as an increasingly attractive target in various fields of human medicine, with the advantage that several very specific and effective inhibitors are already available. Here, we review the literature on CK2 implication in different human pathologies and evaluate its potential as a pharmacological target in the light of the most recent findings.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045
Cho, N. H., Shaw, J. E., Karuranga, S., Huang, Y., da Rocha Fernandes, J. D., Ohlrogge, A. W., & Malanda, B. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.02.023 · Cited by 7,283 · cited 1×
“CK2 in diabetes and obesity Diabetes mellitus (DM), usually known as diabetes, is a metabolic disease characterized by chronic hyperglycemia, whose worldwide prevalence has been rapidly rising in the past decades.(251) The main subtypes of DM are type 1 diabetes mellitus (T1DM), which is associated to a defective insu…”
Background2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s002 · Cited by 4,792
A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
Gordon, D. E., Jang, G. M., Bouhaddou, M., Xu, J., Obernier, K., White, K. M., O’Meara, M. J., Rezelj, V. V., Guo, J. Z., Swaney, D. L., et al. (2020) · Nature · doi:10.1038/s41586-020-2286-9 · Cited by 4,405
Webb, A. K. (2006) · Cited by 4,369
2. Classification and Diagnosis of Diabetes:Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s002 · Cited by 2,697
Amyloid Precursor Protein Processing and Alzheimer's Disease
O'Brien, R. J., & Wong, P. C. (2011) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-061010-113613 · Cited by 2,061 · cited 1×
“AD is a progressive neurodegeneration, characterized by the presence in amyloid plaques of amyloid β-peptide (Aβ), which is produced by sequential cleavage of amyloid precursor protein (APP) by the β- and the γ-secretases.(161) There are numerous evidence for CK2 implication in AD.”
BackgroundElborn, J. S. (2016) · The Lancet · doi:10.1016/s0140-6736(16)00576-6 · Cited by 1,805
Principles of cancer therapy: oncogene and non-oncogene addiction
Luo, J., Solimini, N. L., & Elledge, S. J. (2009) · Cell · doi:10.1016/j.cell.2009.02.024 · Cited by 1,765
The many faces of α-synuclein: from structure and toxicity to therapeutic target
Lashuel, H. A., Overk, C. R., Oueslati, A., & Masliah, E. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3406 · Cited by 1,622
One‐thousand‐and‐one substrates of protein kinase CK2?
Meggio, F., & Pinna, L. A. (2003) · The FASEB Journal · doi:10.1096/fj.02-0473rev · Cited by 1,310
The Global Phosphorylation Landscape of SARS-CoV-2 Infection
Bouhaddou, M., Memon, D., Meyer, B., White, K. M., Rezelj, V. V., Correa Marrero, M., Polacco, B. J., Melnyk, J. E., Ulferts, S., Kaake, R. M., et al. (2020) · Cell · doi:10.1016/j.cell.2020.06.034 · Cited by 1,020
Phosphorylated TDP‐43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis
Hasegawa, M., Arai, T., Nonaka, T., Kametani, F., Yoshida, M., Hashizume, Y., Beach, T. G., Buratti, E., Baralle, F., Morita, M., et al. (2008) · Annals of Neurology · doi:10.1002/ana.21425 · Cited by 777 · cited 1×
“In fact, none of them is surrounded by acidic residues, a general requirement for the CK2 phosphorylation (GGFGS403S404MDSK MDSKS409S410GWGM), 156 and in vitro experiments suggest that CK1 could play the main role in the modification of these sites.(181,182) In accordance with a protective role of CK2 in ALS, a diseas…”
BackgroundHuntington disease: new insights into molecular pathogenesis and therapeutic opportunities
Tabrizi, S. J., Flower, M. D., Ross, C. A., & Wild, E. J. (2020) · Nature Reviews Neurology · doi:10.1038/s41582-020-0389-4 · Cited by 538
Constitutive Phosphorylation of the Parkinson's Disease Associated α-Synuclein
Okochi, M., Walter, J., Koyama, A., Nakajo, S., Baba, M., Iwatsubo, T., Meijer, L., Kahle, P. J., & Haass, C. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.1.390 · Cited by 519
Siddiqui-Jain, A., Drygin, D., Streiner, N., Chua, P., Pierre, F., O'Brien, S. E., Bliesath, J., Omori, M., Huser, N., Ho, C., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1893 · Cited by 506
Protein kinase CK2: a challenge to canons
Pinna, L. A. (2002) · Journal of Cell Science · doi:10.1242/jcs.00074 · Cited by 492
Wang, D., Westerheide, S. D., Hanson, J. L., & Baldwin, A. S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m001358200 · Cited by 454
Role of CFTR in epithelial physiology
Saint-Criq, V., & Gray, M. A. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2391-y · Cited by 433
Zhou, H., Zhu, P., Wang, J., Zhu, H., Ren, J., & Chen, Y. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-018-0086-7 · Cited by 416
Casein Kinase IIα Transgene-Induced Murine Lymphoma: Relation to Theileriosis in Cattle
Seldin, D. C., & Leder, P. (1995) · Science · doi:10.1126/science.7846532 · Cited by 395
Golding, S. E., Rosenberg, E., Valerie, N., Hussaini, I., Frigerio, M., Cockcroft, X. F., Chong, W. Y., Hummersone, M., Rigoreau, L., Menear, K. A., et al. (2009) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0519 · Cited by 385
Oueslati, A. (2016) · Journal of Parkinson’s Disease · doi:10.3233/jpd-160779 · Cited by 375
Sarno, S., Reddy, H., Meggio, F., Ruzzene, M., Davies, S. P., Donella-Deana, A., Shugar, D., & Pinna, L. A. (2001) · FEBS Letters · doi:10.1016/s0014-5793(01)02404-8 · Cited by 356
Self-citationProtein Kinase CK2 in Health and Disease: CK2: A key player in cancer biology
Trembley, J. H., Wang, G., Unger, G., Slaton, J., & Ahmed, K. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-9154-y · Cited by 354
Addiction to protein kinase CK2: A common denominator of diverse cancer cells?
Ruzzene, M., & Pinna, L. A. (2010) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.07.018 · Cited by 352
Self-citationAn AUTS2–Polycomb complex activates gene expression in the CNS
Gao, Z., Lee, P., Stafford, J. M., von Schimmelmann, M., Schaefer, A., & Reinberg, D. (2014) · Nature · doi:10.1038/nature13921 · Cited by 320
Marselli, L., Thorne, J., Dahiya, S., Sgroi, D. C., Sharma, A., Bonner-Weir, S., Marchetti, P., & Weir, G. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011499 · Cited by 313
Duncan, J. S., & Litchfield, D. W. (2008) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2007.08.017 · Cited by 304
Sannerud, R., Esselens, C., Ejsmont, P., Mattera, R., Rochin, L., Tharkeshwar, A. K., De Baets, G., De Wever, V., Habets, R., Baert, V., et al. (2016) · Cell · doi:10.1016/j.cell.2016.05.020 · Cited by 299
Pierre, F., Chua, P. C., O’Brien, S. E., Siddiqui-Jain, A., Bourbon, P., Haddach, M., Michaux, J., Nagasawa, J., Schwaebe, M. K., Stefan, E., et al. (2011) · Journal of Medicinal Chemistry · doi:10.1021/jm101251q · Cited by 296
A CK2-Dependent Mechanism for Degradation of the PML Tumor Suppressor
Scaglioni, P. P., Yung, T. M., Cai, L. F., Erdjument-Bromage, H., Kaufman, A. J., Singh, B., Teruya-Feldstein, J., Tempst, P., & Pandolfi, P. P. (2006) · Cell · doi:10.1016/j.cell.2006.05.041 · Cited by 295
Protein kinase CK2 in mammary gland tumorigenesis
Landesman-Bollag, E., Romieu-Mourez, R., Song, D. H., Sonenshein, G. E., Cardiff, R. D., & Seldin, D. C. (2001) · Oncogene · doi:10.1038/sj.onc.1204411 · Cited by 289
Future trends in cystic fibrosis demography in 34 European countries
Burgel, P.-R., Bellis, G., Olesen, H. V., Viviani, L., Zolin, A., Blasi, F., & Elborn, J. S. (2015) · European Respiratory Journal · doi:10.1183/09031936.00196314 · Cited by 282
St-Denis, N. A., & Litchfield, D. W. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-9150-2 · Cited by 275
Protein kinase CK2 signal in neoplasia.
Tawfic, S. H., Yu, S., Wang, H., Faust, R. A., Davis, A. T., & Ahmed, K. (2001) · PubMed · doi:10.14670/hh-16.573 · Cited by 259
Phosphorylation of Synucleins by Members of the Polo-like Kinase Family
Mbefo, M. K., Paleologou, K. E., Boucharaba, A., Oueslati, A., Schell, H., Fournier, M., Olschewski, D., Yin, G., Zweckstetter, M., Masliah, E., et al. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.081950 · Cited by 246
The selectivity of inhibitors of protein kinase CK2: an update
Pagano, M. A., Bain, J., Kazimierczuk, Z., Sarno, S., Ruzzene, M., Di Maira, G., Elliott, M., Orzeszko, A., Cozza, G., Meggio, F., et al. (2008) · Biochemical Journal · doi:10.1042/bj20080309 · Cited by 242
Self-citationProtein Kinase CK2 in Human Diseases
Guerra, B., & Issinger, O.-G. (2008) · Current Medicinal Chemistry · doi:10.2174/092986708785132933 · Cited by 242
Polo-like Kinase 2 (PLK2) Phosphorylates α-Synuclein at Serine 129 in Central Nervous System
Inglis, K. J., Chereau, D., Brigham, E. F., Chiou, S.-S., Schöbel, S., Frigon, N. L., Yu, M., Caccavello, R. J., Nelson, S., Motter, R., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.c800206200 · Cited by 240
Walter, J., Capell, A., Grünberg, J., Pesold, B., Schindzielorz, A., Prior, R., Podlisny, M. B., Fraser, P., St. George Hyslop, P., Selkoe, D. J., et al. (1996) · Molecular Medicine · doi:10.1007/bf03401652 · Cited by 229
Disruption of fast axonal transport is a pathogenic mechanism for intraneuronal amyloid beta
Pigino, G., Morfini, G., Atagi, Y., Deshpande, A., Yu, C., Jungbauer, L., LaDu, M., Busciglio, J., & Brady, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0901229106 · Cited by 227
Kanaan, N. M., Pigino, G. F., Brady, S. T., Lazarov, O., Binder, L. I., & Morfini, G. A. (2013) · Experimental Neurology · doi:10.1016/j.expneurol.2012.06.003 · Cited by 212
Kinase inhibitors modulate huntingtin cell localization and toxicity
Atwal, R. S., Desmond, C. R., Caron, N., Maiuri, T., Xia, J., Sipione, S., & Truant, R. (2011) · Nature Chemical Biology · doi:10.1038/nchembio.582 · Cited by 204 · cited 1×
“HTT, and displays a more cytoplasmic localization, while phospho-mimetic mutant restores the nuclear localization and reduces the cellular toxicity of polyQ‐HTT.(173) Although CK2 inhibitors reduce Ser13 and Ser16 phosphorylation, further work will be necessary to verify if HTT is a direct CK2 substrate or an indirect…”
BackgroundDiagnostic Markers of Ovarian Cancer by High-Throughput Antigen Cloning and Detection on Arrays
Chatterjee, M., Mohapatra, S., Ionan, A., Bawa, G., Ali-Fehmi, R., Wang, X., Nowak, J., Ye, B., Nahhas, F. A., Lu, K., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-04-2962 · Cited by 202
Dominguez, I., Sonenshein, G. E., & Seldin, D. C. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-9153-z · Cited by 201
Emergence of protein kinase CK2 as a key target in cancer therapy
Trembley, J. H., Chen, Z., Unger, G., Slaton, J., Kren, B. T., Van Waes, C., & Ahmed, K. (2010) · BioFactors · doi:10.1002/biof.96 · Cited by 194
TDP-43 post-translational modifications in health and disease
Buratti, E. (2018) · Expert Opinion on Therapeutic Targets · doi:10.1080/14728222.2018.1439923 · Cited by 186
Extraordinary pleiotropy of protein kinase CK2 revealed by weblogo phosphoproteome analysis
Salvi, M., Sarno, S., Cesaro, L., Nakamura, H., & Pinna, L. A. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2009.01.013 · Cited by 178
Self-citationBattistutta, R., Cozza, G., Pierre, F., Papinutto, E., Lolli, G., Sarno, S., O’Brien, S. E., Siddiqui-Jain, A., Haddach, M., Anderes, K., et al. (2011) · Biochemistry · doi:10.1021/bi2008382 · Cited by 173
Self-citationCK2 in Cancer: Cellular and Biochemical Mechanisms and Potential Therapeutic Target
Chua, M., Ortega, C., Sheikh, A., Lee, M., Abdul-Rassoul, H., Hartshorn, K., & Dominguez, I. (2017) · Pharmaceuticals · doi:10.3390/ph10010018 · Cited by 172
Asymmetric Expression of Protein Kinase CK2 Subunits in Human Kidney Tumors
Stalter, G., Siemer, S., Becht, E., Ziegler, M., Remberger, K., & Issinger, O. G. (1994) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1994.1904 · Cited by 161
Faust, R. A., Gapany, M., Tristani, P., Davis, A., Adams, G. L., & Ahmed, K. (1996) · Cancer Letters · doi:10.1016/0304-3835(96)04110-9 · Cited by 161
Cell Signaling by the Type IV Pili of Pathogenic Neisseria
Källström, H., Islam, M. S., Berggren, P.-O., & Jonsson, A.-B. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21777 · Cited by 161
Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2
Cozza, G., Mazzorana, M., Papinutto, E., Bain, J., Elliott, M., di Maira, G., Gianoncelli, A., Pagano, M. A., Sarno, S., Ruzzene, M., et al. (2009) · Biochemical Journal · doi:10.1042/bj20090069 · Cited by 158
Self-citationBattistutta, R., Moliner, E. D., Sarno, S., Zanotti, G., & Pinna, L. A. (2001) · Protein Science · doi:10.1110/ps.19601 · Cited by 155
Self-citationPierre, F., Chua, P. C., O’Brien, S., Siddiqui-Jain, A., Bourbon, P., Haddach, M., Michaux, J., Nagasawa, J. Y., Schwaebe, M. K., Stefan, E., et al. (2011) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-011-0956-5 · Cited by 153
Casein kinase: the triple meaning of a misnomer
Venerando, A., Ruzzene, M., & Pinna, L. A. (2014) · Biochemical Journal · doi:10.1042/bj20140178 · Cited by 151
Self-citationOrtega, C. E., Isaacs, Y. S., & Dominguez, I. M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115609 · Cited by 147
Daya‐Makin, M., Sanghera, J. S., Mogentale, T. L., Lipp, M. K., Parchomchuk, J., Hogg, J. C., & Pelech, S. (1994) · PubMed · Cited by 143
Targeting Protein Kinase CK2 Suppresses Prosurvival Signaling Pathways and Growth of Glioblastoma
Zheng, Y., McFarland, B. C., Drygin, D., Yu, H., Bellis, S. L., Kim, H., Bredel, M., & Benveniste, E. N. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-13-0265 · Cited by 143
Chen, I.-Y., Chang, S. C., Wu, H.-Y., Yu, T.-C., Wei, W.-C., Lin, S., Chien, C.-L., & Chang, M.-F. (2010) · Journal of Virology · doi:10.1128/jvi.02560-09 · Cited by 141 · cited 1×
“In the context of the recent COVID-19 pandemic caused by SarsCoV-2, it is worth it to mention that the inhibition of CK2 reduces the dysregulated production of inflammatory cytokines in response to SARS-CoV, another member of this virus family.(196) The mechanism has been identified in the prevention of the CK2depende…”
BackgroundSarno, S., Moliner, E. D., Ruzzene, M., Pagano, M. A., Battistutta, R., Bain, J., Fabbro, D., Schoepfer, J. G., Elliott, M., Furet, P., et al. (2003) · Biochemical Journal · doi:10.1042/bj20030674 · Cited by 141
Self-citationRaju, P., Shashikanth, N., Tsai, P.-Y., Pongkorpsakol, P., Chánez-Paredes, S. D., Steinhagen, P., Kuo, W., Singh, G., Tsukita, S., & Turner, J. R. (2020) · Journal of Clinical Investigation · doi:10.1172/jci138697 · Cited by 140
Oshima, T., Niwa, Y., Kuwata, K., Srivastava, A., Hyoda, T., Tsuchiya, Y., Kumagai, M., Tsuyuguchi, M., Tamaru, T., Sugiyama, A., et al. (2019) · Science Advances · doi:10.1126/sciadv.aau9060 · Cited by 138
A CK2-dependent mechanism for activation of the JAK-STAT signaling pathway
Zheng, Y., Qin, H., Frank, S. J., Deng, L., Litchfield, D. W., Tefferi, A., Pardanani, A. D., Lin, F., Li, J., Sha, B., et al. (2011) · Blood · doi:10.1182/blood-2010-01-266320 · Cited by 137
An Experimenter’s Guide to Glioblastoma Invasion Pathways
de Gooijer, M. C., Navarro, M. G., Bernards, R., Würdinger, T., & van Tellingen, O. (2018) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2018.07.003 · Cited by 136
Multiple myeloma cell survival relies on high activity of protein kinase CK2
Piazza, F., Ruzzene, M., Gurrieri, C., Montini, B., Bonanni, L., Chioetto, G., Maira, G. D., Barbon, F., Cabrelle, A., Zambello, R., et al. (2006) · Blood · doi:10.1182/blood-2005-11-013672 · Cited by 135
Self-citationHyperphosphorylation as a Defense Mechanism to Reduce TDP-43 Aggregation
Li, H.-Y., Yeh, P.-A., Chiu, H.-C., Tang, C., & Tu, P. (2011) · PLoS ONE · doi:10.1371/journal.pone.0023075 · Cited by 132
Nuclear casein kinase 2 (CK‐2) activity in human normal, benign hyperplastic, and cancerous prostate
Yenice, S., Davis, A. T., Goueli, S. A., Akdaş, A., Limas, C., & Ahmed, K. (1994) · The Prostate · doi:10.1002/pros.2990240105 · Cited by 131
Hauck, L., Harms, C., An, J., Rohne, J., Gertz, K. R., Dietz, R., Endres, M., & von Harsdorf, R. (2008) · Nature Medicine · doi:10.1038/nm1729 · Cited by 127
Kinase Interaction Network Expands Functional and Disease Roles of Human Kinases
Buljan, M., Ciuffa, R., van Drogen, A., Vichalkovski, A., Mehnert, M., Rosenberger, G., Lee, S., Varjosalo, M. T., Pernas, L. E., Spegg, V., et al. (2020) · Molecular Cell · doi:10.1016/j.molcel.2020.07.001 · Cited by 124
Chen, L., Zhi, Z., Wang, L. Y., Zhao, Y., Deng, M., Liu, Y., Yan, Q., Tian, M., Liu, Y., Shen, T., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5238 · Cited by 123
Protein Kinase CK2 as Regulator of Cell Survival: Implications for Cancer Therapy
Unger, G. M., Davis, A. R., Slaton, J. W., & Ahmed, K. (2004) · Current Cancer Drug Targets · doi:10.2174/1568009043481687 · Cited by 120
Heda, G. D., Tanwani, M., & Marino, C. R. (2001) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.2001.280.1.c166 · Cited by 117
Iguchi, Y., Katsuno, M., Takagi, S., Ishigaki, S., Niwa, J., Hasegawa, M., Tanaka, F., & Sobue, G. (2011) · Neurobiology of Disease · doi:10.1016/j.nbd.2011.12.002 · Cited by 115
CK2-dependent phosphorylation determines cellular localization and stability of ataxin-3
Müeller, T., Breuer, P., Schmitt, I., Walter, J., Evert, B. O., & Wüllner, U. (2009) · Human Molecular Genetics · doi:10.1093/hmg/ddp274 · Cited by 115
Rabalski, A. J., Gyenis, L., & Litchfield, D. W. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1314 · Cited by 113
Role of protein kinase CK2 in antitumor drug resistance
Borgo, C., & Ruzzene, M. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1292-y · Cited by 113
Self-citationProtein kinase CK2, an important regulator of the inflammatory response?
Singh, N. N., & Ramji, D. P. (2008) · Journal of Molecular Medicine · doi:10.1007/s00109-008-0352-0 · Cited by 112
Zou, J., Luo, H., Zeng, Q., Dong, Z., Wu, D., & Liu, L. (2011) · Journal of Translational Medicine · doi:10.1186/1479-5876-9-97 · Cited by 111
Eom, G. H., Cho, Y. K., Ko, J., Shin, S., Choe, N., Kim, Y., Joung, H., Kim, H.-S., Nam, K. I., Kee, H. J., et al. (2011) · Circulation · doi:10.1161/circulationaha.110.003665 · Cited by 111
Ishii, A., Nonaka, T., Taniguchi, S., Saito, T., Arai, T., Mann, D. M. A., Iwatsubo, T., Hisanaga, S., Goedert, M., & Hasegawa, M. (2007) · FEBS Letters · doi:10.1016/j.febslet.2007.08.067 · Cited by 111
Siddiqui-Jain, A., Bliesath, J. R., Macalino, D., Omori, M., Huser, N. H., Streiner, N., Ho, C., Anderes, K. L., Proffitt, C., O’Brien, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-11-0613 · Cited by 109
Role for casein kinase 2 in the regulation of HIF‐1 activity
Mottet, D., Ruys, S. P. D., Demazy, C., Raes, M. J., & Michiels, C. (2005) · International Journal of Cancer · doi:10.1002/ijc.21268 · Cited by 108
Structure-based design of small peptide inhibitors of protein kinase CK2 subunit interaction
Laudet, B., Barette, C., Duléry, V., Renaudet, O., Dumy, P., Metz, A., Prudent, R., Deshière, A., Dideberg, O., Filhol, O., et al. (2007) · Biochemical Journal · doi:10.1042/bj20070825 · Cited by 107
Increased occurrence of protein kinase CK2 in astrocytes in Alzheimer’s disease pathology
Rosenberger, A. F. N., Morrema, T. H. J., Gerritsen, W. H., van Haastert, E. S., Snkhchyan, H., Hilhorst, R., Rozemüller, A. J. M., Scheltens, P., van der Vies, S. M., & Hoozemans, J. J. M. (2016) · Journal of Neuroinflammation · doi:10.1186/s12974-015-0470-x · Cited by 107
Casein kinases as potential therapeutic targets
Cozza, G., & Pinna, L. A. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2016.1091883 · Cited by 105
Regulation of casein kinase II by growth factors: a reevaluation.
Litchfield, D. W., Dobrowolska, G., & Krebs, E. G. (1994) · PubMed · Cited by 104
Sacco, F., Humphrey, S. J., Cox, J., Mischnik, M., Schulte, A. M., Klabunde, T., Schäfer, M., & Mann, M. (2016) · Nature Communications · doi:10.1038/ncomms13250 · Cited by 104
Piazza, F., Manni, S., Ruzzene, M., Pinna, L. A., Gurrieri, C., & Semenzato, G. (2012) · Leukemia · doi:10.1038/leu.2011.385 · Cited by 102
Self-citationPerea, S. E., Reyes, O., Baladrón, I., Perera, Y., Fariña, H. G., Gil, J., Rodríguez, A., Bacardí, D., Marcelo, J., Cosme, K., et al. (2008) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-008-9814-5 · Cited by 101
Shinoda, K., Ohyama, K., Hasegawa, Y., Chang, H., Ogura, M., Sato, A., Hong, H., Hosono, T., Sharp, L. Z., Scheel, D. W., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.09.029 · Cited by 101
Cox, M. L., & Meek, D. W. (2009) · Cellular Signalling · doi:10.1016/j.cellsig.2009.11.014 · Cited by 100
Identification of a Novel Function of CX-4945 as a Splicing Regulator
Kim, H., Choi, K., Kang, H., Lee, S., Chi, S., Lee, M., Jaehyoung, S., Donghwa, I., Choi, Y., & Cho, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094978 · Cited by 99
Protein Kinase CK2 in Health and Disease: CK2: The kinase controlling the Hsp90 chaperone machinery
Miyata, Y. (2009) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-009-9152-0 · Cited by 98
The E7 protein of human papillomavirus type 16 is phosphorylated by casein kinase II.
Firzlaff, J. M., Galloway, D. A., Eisenman, R. N., & Lüscher, B. (1989) · PubMed · Cited by 97
Casein Kinase 2 Promotes Hedgehog Signaling by Regulating both Smoothened and Cubitus Interruptus
Jia, H., Liu, Y., Xia, R., Tong, C., Yue, T., Jiang, J., & Jia, J. (2010) · Journal of Biological Chemistry · doi:10.1074/jbc.m110.174565 · Cited by 97
Regulation of cell proliferation and survival: Convergence of protein kinases and caspases
Duncan, J. S., Turowec, J. P., Vilk, G., Li, S. S. ‐., Gloor, G. B., & Litchfield, D. W. (2009) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2009.11.001 · Cited by 96
SIRT6 Is Essential for Adipocyte Differentiation by Regulating Mitotic Clonal Expansion
Chen, Q., Hao, W., Xiao, C., Wang, R.-H., Xu, X., Lü, H., Chen, W., & Deng, C. (2017) · Cell Reports · doi:10.1016/j.celrep.2017.03.006 · Cited by 93
Role of CK2 inhibitor CX-4945 in anti-cancer combination therapy – potential clinical relevance
D’Amore, C., Borgo, C., Sarno, S., & Salvi, M. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00566-w · Cited by 93
Self-citationTosco, A., De Gregorio, F., Esposito, S., De Stefano, D., Sana, I., Ferrari, E., Sepe, A., Salvadori, L., Buonpensiero, P., Di Pasqua, A., et al. (2016) · Cell Death & Differentiation · doi:10.1038/cdd.2016.22 · Cited by 92 · cited 1×
“However, although not effective in Phe508del-CFTR rescuing per se, CK2 inhibition mediated by epigallocatechin gallate was able to potentiate the effect of cysteamine, a proteostasis regulator that has been shown to promote CFTR maturation.(226) Interestingly, an in vitro analysis highlighted a possible mutual mechani…”
BackgroundManni, S., Brancalion, A., Mandato, E., Tubi, L. Q., Colpo, A., Pizzi, M., Cappellesso, R., Zaffino, F., Maggio, S. A. D., Cabrelle, A., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075280 · Cited by 92
Kim, S., & Kahn, R. (1997) · Biochemical Journal · doi:10.1042/bj3230621 · Cited by 89
Sang, B., & Barbosa, M. S. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.17.8063 · Cited by 89
Manni, S., Brancalion, A., Tubi, L. Q., Colpo, A., Pavan, L., Cabrelle, A., Ave, E., Zaffino, F., Maira, G. D., Ruzzene, M., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1789 · Cited by 89
Self-citationBae, J. S., Park, S., Jamiyandorj, U., Kim, K. M., Noh, S. J., Kim, J. R., Park, H. J., Kwon, K. S., Jung, S. H., Park, H. S., et al. (2016) · American Journal Of Pathology · doi:10.1016/j.ajpath.2016.08.007 · Cited by 88
Okur, V., Cho, M. T., Henderson, L. B., Retterer, K., Schneider, M., Sattler, S. G., Niyazov, D., Azage, M., Smith, S. E., Picker, J. D., et al. (2016) · Human Genetics · doi:10.1007/s00439-016-1661-y · Cited by 87
Gomes, A. M., Soares, M. V. D., Ribeiro, P. R., Caldas, J., Póvoa, V., Martins, L. R., Melão, A., Serra‐Caetano, A., Sousa, A. B., de Lacerda, J. F., et al. (2014) · Haematologica · doi:10.3324/haematol.2013.096438 · Cited by 86
Tuncay, E., Bitirim, C. V., Durak, A. T., Carrat, G., Taylor, K. M., Rutter, G. A., & Turan, B. (2017) · Diabetes · doi:10.2337/db16-1099 · Cited by 86
Schwartz, E. I., Intine, R. V. A., & Maraia, R. J. (2004) · Molecular and Cellular Biology · doi:10.1128/mcb.24.21.9580-9591.2004 · Cited by 85
Gray, G. K., McFarland, B. C., Rowse, A. L., Gibson, S. A., & Benveniste, E. N. (2014) · Oncotarget · doi:10.18632/oncotarget.2248 · Cited by 84
Alternative polyadenylation drives oncogenic gene expression in pancreatic ductal adenocarcinoma
Venkat, S., Tisdale, A. A., Schwarz, J. R., Alahmari, A. A., Maurer, H. C., Olive, K. P., Eng, K. H., & Feigin, M. E. (2020) · Genome Research · doi:10.1101/gr.257550.119 · Cited by 84
Buontempo, F., Orsini, E., Martins, L. R., Antunes, I., Lonetti, A., Chiarini, F., Tabellini, G., Evangelisti, C., Evangelisti, C., Melchionda, F., et al. (2013) · Leukemia · doi:10.1038/leu.2013.349 · Cited by 83
Kim, J., & Kim, S. H. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074342 · Cited by 81
Wu, F., Qiu, J., Yang, F., Zhang, Q., Cheng, B., Wu, Y., & Bai, B. (2018) · Experimental Neurology · doi:10.1016/j.expneurol.2018.01.006 · Cited by 81
SLITRK1 Binds 14-3-3 and Regulates Neurite Outgrowth in a Phosphorylation-Dependent Manner
Kajiwara, Y., Buxbaum, J. D., & Grice, D. E. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.05.033 · Cited by 80
Solares, A. M., Santana, A., Baladrón, I., Valenzuela, C., Gonzalez, C. A., Díaz, A., Castillo, D., Ramos, T. I., Gómez, R., Alonso, D. F., et al. (2009) · BMC Cancer · doi:10.1186/1471-2407-9-146 · Cited by 80
Purzner, T., Purzner, J., Buckstaff, T. M., Cozza, G., Gholamin, S., Rusert, J. M., Hartl, T. A., Sanders, J., Conley, N. R., Ge, X., et al. (2018) · Science Signaling · doi:10.1126/scisignal.aau5147 · Cited by 80
Kinases, tails and more: Regulation of PTEN function by phosphorylation
Fragoso, R., & Barata, J. T. (2014) · Methods · doi:10.1016/j.ymeth.2014.10.015 · Cited by 79
Involvement of Protein Kinase CK2 in Angiogenesis and Retinal Neovascularization
Ljubimov, A. V., Caballero, S., Aoki, A. M., Pinna, L. A., Grant, M. B., & Castellon, R. (2004) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.04-0686 · Cited by 79
Nakashima, M., Tohyama, J., Nakagawa, E., Watanabe, Y., Siew, C. G., Kwong, C. S., Yamoto, K., Hiraide, T., Fukuda, T., Kaname, T., et al. (2019) · Journal of Human Genetics · doi:10.1038/s10038-018-0559-z · Cited by 78
Deshière, A., Duchemin-Pelletier, E., Spreux, E., Ciais, D., Combes, F., Vandenbrouck, Y., Couté, Y., Mikaélian, I., Giusiano, S., Charpin, C., et al. (2012) · Oncogene · doi:10.1038/onc.2012.165 · Cited by 77
Activity of the clinical-stage CK2-specific inhibitor CX-4945 against chronic lymphocytic leukemia
Martins, L. R., Lúcio, P., Melão, A., Antunes, I., Cardoso, B. A., Stansfield, R. K., Bertilaccio, M. T. S., Ghia, P., Drygin, D., da Silva, M. G., et al. (2013) · Leukemia · doi:10.1038/leu.2013.232 · Cited by 76
Profiling of Protein Kinases in the Neoplastic Transformation of Human Ovarian Surface Epithelium
Wong, A. S. T., Kim, S. O., Leung, P. C. K., Auersperg, N., & Pelech, S. (2001) · Gynecologic Oncology · doi:10.1006/gyno.2001.6280 · Cited by 76
Silva, A., Jotta, P. Y., Silveira, A. B., Ribeiro, D., Brandalise, S. R., Yunes, J. A., & Barata, J. T. (2009) · Haematologica · doi:10.3324/haematol.2009.011999 · Cited by 76
Protein kinase CK2 modulates IL-6 expression in inflammatory breast cancer
Drygin, D., Ho, C., Omori, M., Bliesath, J. R., Proffitt, C., Rice, R. A., Siddiqui-Jain, A., O’Brien, S., Padgett, C. S., Lim, J. K. C., et al. (2011) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2011.10.046 · Cited by 73
The Development of CK2 Inhibitors: From Traditional Pharmacology to in Silico Rational Drug Design
Cozza, G. (2017) · Pharmaceuticals · doi:10.3390/ph10010026 · Cited by 73
Poirier, K., Hubert, L., Viot, G., Rio, M., Billuart, P., Besmond, C., & Bienvenu, T. (2017) · Human Mutation · doi:10.1002/humu.23270 · Cited by 73
Bowie, L. E., Maiuri, T., Alpaugh, M., Gabriel, M. A., Arbez, N., Galleguillos, D., Hung, C. L.-K., Patel, S., Xia, J., Hertz, N. T., et al. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1801772115 · Cited by 69
Cancer-type dependent expression of CK2 transcripts
Chua, M. M. J., Lee, M., & Dominguez, I. M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188854 · Cited by 68
Inhibition of Human Papillomavirus Type 16 E7 Phosphorylation by the S100 MRP-8/14 Protein Complex
Tugizov, S. M., Berline, J. W., Herrera, R., Peñaranda, M. E., Nakagawa, M., & Palefsky, J. M. (2004) · Journal of Virology · doi:10.1128/jvi.79.2.1099-1112.2005 · Cited by 67
Giusiano, S., Cochet, C., Filhol, O., Duchemin-Pelletier, E., Secq, V., Bonnier, P., Carcopino, X., Boubli, L., Birnbaum, D., Garcia, S., et al. (2010) · European Journal of Cancer · doi:10.1016/j.ejca.2010.11.028 · Cited by 65
Silva-Pavez, E., Villar, P., Trigo, C., Caamaño, E., Niechi, I., Pérez, P. E., Muñoz, J. P., Aguayo, F., Burzio, V. A., Varas‐Godoy, M., et al. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1306-x · Cited by 64
Cozza, G., Girardi, C., Ranchio, A., et al. (2014) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1552-5 · Cited by 62
Tubi, L. Q., Gurrieri, C., Brancalion, A., Bonaldi, L., Bertorelle, R., Manni, S., Pavan, L., Lessi, F., Zambello, R., Trentin, L., et al. (2013) · Journal of Hematology & Oncology · doi:10.1186/1756-8722-6-78 · Cited by 62
Self-citationDeficits in Syntaxin 1 Phosphorylation in Schizophrenia Prefrontal Cortex
Castillo, M. A., Ghose, S., Tamminga, C. A., & Ulery, P. G. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2009.07.029 · Cited by 61
Cozza, G., Gianoncelli, A., Bonvini, P., Zorzi, E., Pasquale, R., Rosolen, A., Pinna, L. A., Meggio, F., Zagotto, G., & Moro, S. (2011) · ChemMedChem · doi:10.1002/cmdc.201100338 · Cited by 61
Cross-talk between the CK2 and AKT signaling pathways in cancer
Ruzzene, M., Bertacchini, J., Toker, A., & Marmiroli, S. (2017) · Advances in Biological Regulation · doi:10.1016/j.jbior.2017.03.002 · Cited by 61
Self-citationKhan, D. H., He, S., Yu, J. J., Winter, S., Cao, W., Seiser, C., & Davie, J. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.440446 · Cited by 60
Candida albicans protein kinase CK2 governs virulence during oropharyngeal candidiasis
Chiang, L. Y., Sheppard, D. C., Bruno, V. M., Mitchell, A. P., Edwards, J. E., & Filler, S. G. (2007) · Cellular Microbiology · doi:10.1111/j.1462-5822.2006.00784.x · Cited by 59
Morooka, S., Hoshina, M., Kii, I., Okabe, T., Kojima, H., Inoue, N., Okuno, Y., Denawa, M., Yoshida, S., Fukuhara, J., et al. (2015) · Molecular Pharmacology · doi:10.1124/mol.114.097345 · Cited by 59
Yadikar, H., Torres, I., Aiello, G., Kurup, M., Yang, Z., Lin, F. Y., Kobeissy, F. H., Yost, R. A., & Wang, K. (2020) · PLoS ONE · doi:10.1371/journal.pone.0224952 · Cited by 59
CIGB-300: A peptide-based drug that impairs the Protein Kinase CK2-mediated phosphorylation
Perea, S. E., Baladrón, I., Valenzuela, C., & Perera, Y. (2018) · Seminars in Oncology · doi:10.1053/j.seminoncol.2018.04.006 · Cited by 58
Protein Kinase CK2 in Cancer Energetics
Silva-Pavez, E., & Tapia, J. C. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00893 · Cited by 58
Filhol, O., Giacosa, S., Wallez, Y., & Cochet, C. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1929-8 · Cited by 57
Pierre, F., Stefan, E., Nédellec, A.-S., Chevrel, M.-C., Regan, C. F., Siddiqui-Jain, A., Macalino, D., Streiner, N., Drygin, D., Haddach, M., et al. (2011) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2011.09.059 · Cited by 57
Small molecule modulators targeting protein kinase CK1 and CK2
Qiao, Y., Chen, T., Yang, H., Chen, Y., Lin, H., Qu, W., Feng, F., Liu, W., Guo, Q., Liu, Z., et al. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.111581 · Cited by 57
Regulation of Amyloid Precursor Protein Processing by Serotonin Signaling
Pimenova, A. A., Thathiah, A., Strooper, B. D., & Tesseur, I. C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0087014 · Cited by 56
Nitta, R. T., Gholamin, S., Feroze, A. H., Agarwal, M., Cheshier, S. H., Mitra, S. S., & Li, G. (2014) · Oncogene · doi:10.1038/onc.2014.299 · Cited by 54
Prins, R. C., Burke, R. T., Tyner, J. W., Druker, B. J., Loriaux, M., & Spurgeon, S. E. F. (2013) · Leukemia · doi:10.1038/leu.2013.228 · Cited by 54
Casein Kinase II Controls TBK1/IRF3 Activation in IFN Response against Viral Infection
Du, M., Liu, J., Chen, X., Xie, Y., Yuan, C., Yu, X., Sun, B., Lan, K., Chen, M., James, S. J., et al. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402777 · Cited by 51
Kim, S. O., Baines, C. P., Critz, S. D., Pelech, S., Katz, S., Downey, J. M., & Cohen, M. V. (1999) · Biochemistry and Cell Biology · doi:10.1139/bcb-77-6-559 · Cited by 51
Koch, S., Capaldo, C., Hilgarth, R., Fournier, B., Parkos, C. A., & Nusrat, A. (2012) · Mucosal Immunology · doi:10.1038/mi.2012.57 · Cited by 51
Bergeron, M., Motter, R. N., Tanaka, P., Fauss, D., Babcock, M., Chiou, S.-S., Nelson, S., Pablo, F. S., & Anderson, J. P. (2013) · Neuroscience · doi:10.1016/j.neuroscience.2013.09.061 · Cited by 51
CK2 Phosphorylating I2PP2A/SET Mediates Tau Pathology and Cognitive Impairment
Zhang, Q., Xia, Y., Wang, Y., Shentu, Y., Zeng, K., Mahaman, Y. A. R., Huang, F., Wu, M., Ke, D., Wang, Q., et al. (2018) · Frontiers in Molecular Neuroscience · doi:10.3389/fnmol.2018.00146 · Cited by 51
Aksenova, M. V., Burbaeva, G. S., Kandror, K. V., Kapkov, D. V., & Stepanov, A. S. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80249-3 · Cited by 50
Chiu, A. T. G., Pei, S. L. C., Mak, C. C. Y., Leung, G. K. C., Yu, M. H. C., Lee, S. L., Vreeburg, M., Pfundt, R., van der Burgt, I., Kleefstra, T., et al. (2017) · Clinical Genetics · doi:10.1111/cge.13196 · Cited by 50
Hora, R., Bridges, D. J., Craig, A. G., & Sharma, A. K. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m809756200 · Cited by 49
Amyloid β-protein stimulates casein kinase I and casein kinase II activities
Chauhan, A., Chauhan, V. P. S., Murakami, N., Brockerhoff, H., & Wísniewski, H. M. (1993) · Brain Research · doi:10.1016/0006-8993(93)90479-7 · Cited by 49
Ko, H., Kim, S., Jin, C., Lee, E., Ham, S., Yook, J. I., & Kim, K. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0261 · Cited by 48
Cardiotrophin 1 stimulates beneficial myogenic and vascular remodeling of the heart
Abdul‐Ghani, M., Suen, C. M., Jiang, B., Deng, Y., Weldrick, J. J., Putinski, C., Brunette, S., Fernando, P., Lee, T. T., Flynn, P., et al. (2017) · Cell Research · doi:10.1038/cr.2017.87 · Cited by 48
Regulatory Mimicry in Listeria monocytogenes Actin-Based Motility
Chong, R., Swiss, R. L., Briones, G., Stone, K. L., Gulcicek, E. E., & Agaisse, H. (2009) · Cell Host & Microbe · doi:10.1016/j.chom.2009.08.006 · Cited by 47
CK2 phosphorylation of Pdx-1 regulates its transcription factor activity
Meng, R., Al-Quobaili, F., Müller, I., Götz, C., Thiel, G., & Montenarh, M. (2010) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-010-0348-0 · Cited by 47
Kalathur, M., Toso, A., Chen, J., Revandkar, A., Danzer-Baltzer, C., Guccini, I., Alajati, A., Sarti, M., Pinton, S., Brambilla, L., et al. (2015) · Nature Communications · doi:10.1038/ncomms8227 · Cited by 47
Self-citationMcClure, M. L., Barnes, S., Brodsky, J. L., & Sorscher, E. J. (2016) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00431.2015 · Cited by 47
CX-4945 Induces Methuosis in Cholangiocarcinoma Cell Lines by a CK2-Independent Mechanism
Lertsuwan, J., Lertsuwan, K., Sawasdichai, A., Tasnawijitwong, N., Lee, K., Kitchen, P., Afford, S. C., Gaston, K., Jayaraman, P.-S., & Satayavivad, J. (2018) · Cancers · doi:10.3390/cancers10090283 · Cited by 47
Lettieri, A., Borgo, C., Zanieri, L., D’Amore, C., Oleari, R., Paganoni, A. J. J., Pinna, L. A., Cariboni, A. M., & Salvi, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20235951 · Cited by 45
Self-citationA posttranslational modification code for CFTR maturation is altered in cystic fibrosis
Pankow, S., Bamberger, C., & Yates, J. R. (2019) · Science Signaling · doi:10.1126/scisignal.aan7984 · Cited by 44
Germline de novo variants in CSNK2B in Chinese patients with epilepsy
Li, J., Gao, K., Cai, S., Yin, L., Wang, Y., Huang, S., Zha, J., Hu, W., Yu, S., Yang, Z., et al. (2019) · Scientific Reports · doi:10.1038/s41598-019-53484-9 · Cited by 44
Kweon, S.-M., Wang, B., Rixter, D. D., Lim, J. H., Koga, T., Ishinaga, H., Chen, L., Jono, H., Xu, H., & Li, J. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.10.052 · Cited by 41
Phosphorylation of HIV-1 Rev Protein: Implication of Protein Kinase CK2 and Pro-Directed Kinases
Meggio, F., D’Agostino, D. M., Ciminale, V., Chieco‐Bianchi, L., & Pinna, L. A. (1996) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1996.1392 · Cited by 41
Mammalian FMRP S499 Is Phosphorylated by CK2 and Promotes Secondary Phosphorylation of FMRP
Bartley, C. M., O’Keefe, R. A., Blice‐Baum, A. C., Mihailescu, M., Gong, X., Miyares, L. C., Karaca, E., & Bordey, A. (2016) · eNeuro · doi:10.1523/eneuro.0092-16.2016 · Cited by 41
Chen, L., Huang, R., Chan, M. W., Yan, P. S., Huang, T., Wu, R., Rahmanto, Y. S., Su, P., Weng, Y., Chou, J., et al. (2019) · The Journal of Pathology · doi:10.1002/path.5266 · Cited by 41
Protective up‐regulation of CK2 by mutant huntingtin in cells co‐expressing NMDA receptors
Fan, M., Zhang, H., Hayden, M. R., Pelech, S., & Raymond, L. A. (2007) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2007.05016.x · Cited by 40
Owen, C. I., Bowden, A. R., Parker, M. J., Patterson, J., Patterson, J., Price, S., Sarkar, A., Castle, B., Deshpande, C., Splitt, M. P., et al. (2018) · American Journal of Medical Genetics Part A · doi:10.1002/ajmg.a.38610 · Cited by 40
Identification of a CK2 phosphorylation site in mdm2.
Götz, C., Kartarius, S., Scholtes, P., Nastainczyk, W., & Montenarh, M. (1999) · European Journal of Biochemistry · doi:10.1046/j.1432-1327.1999.00882.x · Cited by 39
Trinh, J., Hüning, I., Budler, N., Hingst, V., Lohmann, K., & Gillessen‐Kaesbach, G. (2017) · Journal of Human Genetics · doi:10.1038/jhg.2017.73 · Cited by 39
Investigation on PLK2 and PLK3 substrate recognition
Salvi, M., Trashi, E., Cozza, G., Franchin, C., Arrigoni, G., & Pinna, L. A. (2012) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2012.07.003 · Cited by 38
Self-citationCK2 regulates 5-HT4 receptor signaling and modulates depressive-like behavior
Castelló, J., LeFrancois, B., Flajolet, M., Greengard, P., Friedman, E., & Rebholz, H. (2017) · Molecular Psychiatry · doi:10.1038/mp.2017.240 · Cited by 38
Protein Kinase CK2, a Potential Therapeutic Target in Carcinoma Management
Lian, H., Su, M., Zhu, Y., Zhou, Y., Soomro, S. H., & Fu, H. Q. (2019) · Asian Pacific Journal of Cancer Prevention · doi:10.31557/apjcp.2019.20.1.23 · Cited by 38
Multitarget Anticancer Agents Based on Histone Deacetylase and Protein Kinase CK2 Inhibitors
Martínez, R., Geronimo, B. D., Pastor, M., Zapico, J. M., Coderch, C., Panchuk, R. R., Skorokhyd, N. R., Masłyk, M., Ramos, A., & de Pascual‐Teresa, B. (2020) · Molecules · doi:10.3390/molecules25071497 · Cited by 38
Kim, H. S., Chang, Y. G., Bae, H. J., Eun, J. W., Shen, Q., Park, S. J., Shin, W. C., Lee, E. K., Park, S., Ahn, Y. M., et al. (2013) · FEBS Journal · doi:10.1111/febs.12652 · Cited by 37
Lee, A., Rayner, S. L., Luca, A. D., Gwee, S. S. L., Morsch, M., Sundaramoorthy, V., Shahheydari, H., Ragagnin, A., Shi, B., Yang, S., et al. (2017) · Open Biology · doi:10.1098/rsob.170058 · Cited by 37
Zakharia, K., Miyabe, K., Wang, Y., Wu, D., Moser, C. D., Borad, M. J., & Roberts, L. R. (2018) · Translational Oncology · doi:10.1016/j.tranon.2018.09.005 · Cited by 37
Protein kinase 2 (CK2) controls CD4+ T cell effector function in the pathogenesis of colitis
Yang, W., Gibson, S. A., Yan, Z., Wei, H., Tao, J., Sha, B., Qin, H., & Benveniste, E. N. (2020) · Mucosal Immunology · doi:10.1038/s41385-020-0258-x · Cited by 37
Zhou, B., Ritt, D. A., Morrison, D. K., Der, C. J., & Cox, A. D. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.712885 · Cited by 36
Protein kinase CK2 inhibition as a pharmacological strategy
Borgo, C., & Ruzzene, M. (2021) · Advances in protein chemistry and structural biology · doi:10.1016/bs.apcsb.2020.09.003 · Cited by 36
Self-citationCharacterization of insulin-stimulated seryl/threonyl protein kinases in rat skeletal muscle
Hei, Y. J., McNeill, J. H., Sanghera, J. S., Diamond, J., Bryer‐Ash, M., & Pelech, S. (1993) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)38638-7 · Cited by 35
Targeting CK2-driven non-oncogene addiction in B-cell tumors
Mandato, E., Manni, S., Zaffino, F., Semenzato, G., & Piazza, F. (2016) · Oncogene · doi:10.1038/onc.2016.86 · Cited by 35
CK2 modulates adipocyte insulin-signaling and is up-regulated in human obesity
Borgo, C., Milan, G., Favaretto, F., Stasi, F., Fabris, R., Salizzato, V., Cesaro, L., Belligoli, A., Sanna, M., Foletto, M., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-17809-w · Cited by 35
Self-citationProtein Kinase CK2—A Putative Target for the Therapy of Diabetes Mellitus?
Ampofo, E., Nalbach, L., Menger, M. D., Montenarh, M., & Götz, C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20184398 · Cited by 35
CSNK2A1 Promotes Gastric Cancer Invasion Through the PI3K-Akt-mTOR Signaling Pathway
Jiang, C., Ma, Z., Zhang, G., Xigui, Y., Du, Q., & Wang, W. (2019) · Cancer Management and Research · doi:10.2147/cmar.s222620 · Cited by 35
Mechanisms Associated with TDP-43 Neurotoxicity in ALS/FTLD
Shenouda, M., Zhang, A. B., Weichert, A., & Robertson, J. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_9 · Cited by 34
Novel players in multiple myeloma pathogenesis: Role of protein kinases CK2 and GSK3
Piazza, F., Manni, S., & Semenzato, G. (2012) · Leukemia Research · doi:10.1016/j.leukres.2012.10.016 · Cited by 33
Refining the clinical phenotype of Okur–Chung neurodevelopmental syndrome
Akahira‐Azuma, M., Tsurusaki, Y., Enomoto, Y., Mitsui, J., & Kurosawa, K. (2018) · Human Genome Variation · doi:10.1038/hgv.2018.11 · Cited by 32
CK2 acts as a potent negative regulator of receptor-mediated insulin release in vitro and in vivo
Rossi, M., de Azúa, I. R., Barella, L. F., Sakamoto, W., Zhu, L., Cui, Y., Lü, H., Rebholz, H., Matschinsky, F. M., Doliba, N. M., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1519430112 · Cited by 31
Jia, Z., Ai, X., Teng, J., Wang, Y., Wang, B., & Zhang, X. (2016) · Tumor Biology · doi:10.1007/s13277-015-4618-1 · Cited by 31
Götz, C., Bachmann, C., & Montenarh, M. (2006) · The Prostate · doi:10.1002/pros.20471 · Cited by 30
Casein Kinase 2: A Novel Player in Glioblastoma Therapy and Cancer Stem Cells
Agarwal, M. (2014) · Journal of Molecular and Genetic Medicine · doi:10.4172/1747-0862.1000094 · Cited by 29
Cellular signaling and epigenetic regulation of gene expression in leukemia
Gowda, C. S., Song, C., Ding, Y., Iyer, S., Dhanyamraju, P. K., McGrath, M., Bamme, Y., Soliman, M., Kane, S., Payne, J. L., et al. (2019) · Advances in Biological Regulation · doi:10.1016/j.jbior.2019.100665 · Cited by 29
Cited by
Potential Autoimmunity Resulting from Molecular Mimicry between SARS-CoV-2 Spike and Human Proteins
Nunez-Castilla, J., Stebliankin, V., Baral, P., Balbin, C. A., Sobhan, M., Cickovski, T., Mondal, A. M., Narasimhan, G., Chapagain, P., Mathee, K., et al. (2022) · Viruses · doi:10.3390/v14071415 · Cited by 100
MOTS-c modulates skeletal muscle function by directly binding and activating CK2
Kumagai, H., Kim, S.-J., Miller, B., Zempo, H., Tanisawa, K., Natsume, T., Lee, S. H., Wan, J., Leelaprachakul, N., Kumagai, M. E., et al. (2024) · iScience · doi:10.1016/j.isci.2024.111212 · Cited by 15
Intrinsically Disordered Regions Define Unique Protein Interaction Networks in CHD Family Remodelers
Tabar, M. S., Parsania, C., Giardina, C., Feng, Y., Wong, A. C. H., Metierre, C., Nagarajah, R., Dhungel, B. P., Rasko, J. E. J., & Bailey, C. G. (2025) · The FASEB Journal · doi:10.1096/fj.202402808rr · Cited by 7
Metadata
- Authors
- Borgo, C., D’Amore, C., Sarno, S., Salvi, M., & Ruzzene, M.
- Venue
- Signal Transduction and Targeted Therapy
- Published
- 2021-05-17
- Volume
- 6
- Issue
- 1
- Pages
- 183-183
- ISSN
- 2059-3635 (ISSN-L)
- OpenAlex
- W3162383196
- Cited by
- 362
- References
- 255
- FWCI
- 16.03
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.